# Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
Canonical URL: https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-third-quarter-2025-results-on-october-30-2025-7ce48064
Ticker: MMSI
Company: Merit Medical
Source: Merit Medical
Published: 2025-10-03 13:25 EST
## Summary

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of...

## Article Body
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).

To access the conference call, please pre-register using the following link . Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link . A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.

| Contacts: |  |
| --- | --- |
| PR/Media Inquiries: | Investor Inquiries: |
| Sarah Comstock | Mike Piccinino, CFA, IRC |
| Merit Medical | ICR Healthcare |
| +1-801-432-2864 | +1-443-213-0509 |
| sarah.comstock@merit.com | mike.piccinino@icrhealthcare.com |
## Recent Company News
- 2026-07-02 20:05 EST — [Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026](https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-second-quarter-2026-results-on-july-30-2026-f3864c0a) — Source: Merit Medical
- 2026-05-19 13:15 EST — [Merit Medical Shareholders Elect Scott R. Ward to Board of Directors](https://biopharmsignal.com/news/MMSI/merit-medical-shareholders-elect-scott-r-ward-to-board-of-directors-b8f2f33a) — Source: Merit Medical
- 2026-05-08 13:25 EST — [Merit Medical to Participate in the Bank of America Healthcare Conference](https://biopharmsignal.com/news/MMSI/merit-medical-to-participate-in-the-bank-of-america-healthcare-conference-20d54d66) — Source: Merit Medical
- 2026-04-30 20:05 EST — [Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance](https://biopharmsignal.com/news/MMSI/merit-medical-reports-first-quarter-2026-results-and-updates-full-year-guidance-651680cc) — Source: Merit Medical
- 2026-04-02 22:00 EST — [Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026](https://biopharmsignal.com/news/MMSI/merit-medical-systems-to-announce-first-quarter-2026-results-on-april-30-2026-1af622dd) — Source: Merit Medical
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)